Protagonist Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Protagonist Therapeutics by Vanguard Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $112M | 3.2M | 34.65 |
2024-03-31 | $92M | 3.2M | 28.93 |
2023-12-31 | $72M | 3.2M | 22.93 |
2023-09-30 | $54M | 3.2M | 16.68 |
2023-06-30 | $87M | 3.1M | 27.62 |
2023-03-31 | $75M | 3.2M | 23.00 |
2022-12-31 | $34M | 3.1M | 10.91 |
2022-06-30 | $22M | 2.7M | 7.91 |
2022-03-31 | $55M | 2.3M | 23.68 |
2021-09-30 | $42M | 2.4M | 17.72 |
2021-06-30 | $103M | 2.3M | 44.88 |
2021-03-31 | $55M | 2.1M | 25.90 |
2020-12-31 | $41M | 2.0M | 20.16 |
2020-09-30 | $30M | 1.6M | 19.55 |
2020-06-30 | $25M | 1.4M | 17.66 |
2020-03-31 | $7.0M | 992k | 7.06 |
2019-12-31 | $7.0M | 990k | 7.05 |
2019-09-30 | $11M | 936k | 12.00 |
2019-03-31 | $8.7M | 700k | 12.43 |
2018-12-31 | $4.3M | 660k | 6.56 |
2018-09-30 | $5.4M | 531k | 10.18 |
2018-06-30 | $3.5M | 517k | 6.79 |
2018-03-31 | $4.5M | 525k | 8.62 |
2017-12-31 | $10M | 483k | 20.81 |
2017-09-30 | $6.3M | 356k | 17.68 |
2017-06-30 | $3.7M | 325k | 11.31 |
2017-03-31 | $4.0M | 314k | 12.78 |
2016-12-31 | $6.8M | 310k | 21.95 |
2016-09-30 | $3.0M | 143k | 21.17 |